Back to User profile » Dr Joshua Sabari
Paper published by Dr Joshua Sabari:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A
OncoTargets and Therapy 2017, 10:1983-1992
Published Date: 6 April 2017